James Green
Translating the complexity of a world in motion into the intelligence you need.
About This Column
James Green is a writer and strategist dedicated to finding the "signal in the noise" of modern progress. Building on a career spent deconstructing the high-stakes world of biotech and medical innovation, James now applies his forensic curiosity to the broader forces of change. He specializes in translating complex technological, market, and social shifts into clear, actionable insights. Whether he is analyzing a disruptive new industry, a shift in global investment, or the future of infrastructure, James provides the critical context needed to understand how today’s breakthroughs will reshape our world tomorrow.
Displaying items 181-200 of 525 in total
FlowForma's G2 Sweep Signals Shift to AI-Native, ROI-Driven Automation
Piko Provisions' Award Win Feeds a Bigger Mission in Hawaiʻi
Beyond Weight Loss: Diabetes Drugs Show Major Mental Health Benefits
AI and Automation Fuel RapDev's Rise on Fastest-Growing List
Geely's AI Overhaul: A Full-Stack Bet on NVIDIA's Ecosystem
Australia Forges Gene Therapy Hub with Key UK Partnership
Excalipoint's $69M Launch Signals New Era for China's Global Biotech Bid
Genprex Gene Therapy Shows Dual-Action Attack on Lung Cancer
Lehigh Reimagines Engineering with $10M Gift for Hands-On Program
Nexus Health Acquires Stratis Group in Major Life Sciences Data Play
XM Cyber Tackles AI Attack Paths to Secure Innovation
Altai Capital Challenges OraSure Board, Citing Value Destruction
Main Street's AI Dilemma: High Hopes Meet a Critical Training Gap
EV Cargo Reforges Future on Global Forwarding, Sells UK Arm to WS Holdco
IVFH Faces a Pivotal Moment with Year-End Earnings Call
XCMG's Tech-Fueled Bid for the North American Heavy Equipment Market
Genspark Unleashes 'AI Employee' with $1.6B Valuation
Olto Acquires Hexus AI to Unify the AI-Powered Buyer Journey
Fox World Travel Deploys AI to Optimize Corporate Hotel Programs
